Serum cytokine levels in chronic progressive multiple sclerosis: interleukin-2 levels parallel tumor necrosis factor-α levels
- 31 July 1991
- journal article
- Published by Elsevier BV in Journal of Neuroimmunology
- Vol. 33 (1), 29-36
- https://doi.org/10.1016/0165-5728(91)90031-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The cytokine networkImmunology Today, 1989
- Cell surface tumor necrosis factor (TNF) accounts for monocyte- and lymphocyte-mediated killing of TNF-resistant target cellsCellular Immunology, 1989
- Correlation of interleukin-1β and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitisThe Journal of Pediatrics, 1989
- The role of interleukin 2 in autoimmunityImmunology Today, 1989
- Tumor necrosis factor alpha (TNFα) and neurological diseases Failure in detecting TNFα in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumoursJournal of Neuroimmunology, 1989
- Interleukin-2 levels in serum and cerebrospinal fluid of multiple sclerosis patientsAnnals of Neurology, 1988
- Elevated Levels of Soluble Interleukin-2 Receptors in Multiple SclerosisNew England Journal of Medicine, 1988
- Elevated Serum Interleukin-2 Levels in Chronic Progressive Multiple SclerosisNew England Journal of Medicine, 1988
- Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitroAnnals of Neurology, 1988
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983